IL147410A0 - L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases - Google Patents

L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases

Info

Publication number
IL147410A0
IL147410A0 IL14741000A IL14741000A IL147410A0 IL 147410 A0 IL147410 A0 IL 147410A0 IL 14741000 A IL14741000 A IL 14741000A IL 14741000 A IL14741000 A IL 14741000A IL 147410 A0 IL147410 A0 IL 147410A0
Authority
IL
Israel
Prior art keywords
propionylcarnitine
acetylcarnitine
diseases
prevention
treatment
Prior art date
Application number
IL14741000A
Other languages
English (en)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of IL147410A0 publication Critical patent/IL147410A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL14741000A 1999-07-28 2000-07-25 L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases IL147410A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000483A IT1306179B1 (it) 1999-07-28 1999-07-28 Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
PCT/IT2000/000313 WO2001007039A2 (en) 1999-07-28 2000-07-25 L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases

Publications (1)

Publication Number Publication Date
IL147410A0 true IL147410A0 (en) 2002-08-14

Family

ID=11406910

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14741000A IL147410A0 (en) 1999-07-28 2000-07-25 L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases

Country Status (20)

Country Link
US (2) US6653349B1 (hu)
EP (1) EP1200077B1 (hu)
AR (1) AR024981A1 (hu)
AT (1) ATE314064T1 (hu)
AU (1) AU779094B2 (hu)
CA (1) CA2378724C (hu)
CZ (1) CZ20024A3 (hu)
DE (1) DE60025215T2 (hu)
DK (1) DK1200077T3 (hu)
ES (1) ES2254206T3 (hu)
HU (1) HU229185B1 (hu)
IL (1) IL147410A0 (hu)
IT (1) IT1306179B1 (hu)
MX (1) MXPA02000911A (hu)
NO (1) NO20020369L (hu)
PL (1) PL208961B1 (hu)
SK (1) SK952002A3 (hu)
TN (1) TNSN00163A1 (hu)
TR (1) TR200200224T2 (hu)
WO (1) WO2001007039A2 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297545B2 (en) * 1999-01-30 2007-11-20 Pediatrix Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry and internal standards therefor
US7011977B2 (en) * 1999-01-30 2006-03-14 Sigma-Tau Pharmaceuticals, Inc. Quantification of carnitine levels in dialysis patients
US7238531B2 (en) * 1999-01-30 2007-07-03 Pediatrix Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
US7709539B2 (en) * 2004-08-11 2010-05-04 Chang Gung University Therapeutic use of resveratrol for hyperglycemia
US20060153934A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and magnesium
CN101287460B (zh) * 2005-08-17 2012-04-25 希尔氏宠物营养品公司 预防和治疗肾病的组合物
ES2385169B1 (es) * 2010-12-22 2013-09-23 Servicio Andaluz De Salud Uso de la l-carnitina y sus composiciones, para el tratamiento y la prevención del daño renal.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246835A (en) * 1991-05-24 1993-09-21 Wakamoto Pharmaceutical Co., Ltd. Method of diagnosing renal diseases
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.
IT1291113B1 (it) 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1295408B1 (it) 1997-10-03 1999-05-12 Sigma Tau Ind Farmaceuti Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.

Also Published As

Publication number Publication date
MXPA02000911A (es) 2002-10-23
TR200200224T2 (tr) 2002-08-21
HUP0202314A3 (en) 2003-03-28
ES2254206T3 (es) 2006-06-16
US20040057994A1 (en) 2004-03-25
SK952002A3 (en) 2002-06-04
DE60025215T2 (de) 2006-07-13
PL208961B1 (pl) 2011-06-30
WO2001007039A3 (en) 2001-03-29
CZ20024A3 (cs) 2002-06-12
US7585896B2 (en) 2009-09-08
NO20020369L (no) 2002-03-21
CA2378724C (en) 2008-10-14
NO20020369D0 (no) 2002-01-23
DE60025215D1 (de) 2006-02-02
ITRM990483A1 (it) 2001-01-28
CA2378724A1 (en) 2001-02-01
EP1200077A2 (en) 2002-05-02
PL354412A1 (en) 2004-01-12
AR024981A1 (es) 2002-11-06
DK1200077T3 (da) 2006-04-24
TNSN00163A1 (fr) 2005-11-10
AU779094B2 (en) 2005-01-06
EP1200077B1 (en) 2005-12-28
ATE314064T1 (de) 2006-01-15
WO2001007039A2 (en) 2001-02-01
AU6469200A (en) 2001-02-13
HU229185B1 (en) 2013-09-30
ITRM990483A0 (it) 1999-07-28
US6653349B1 (en) 2003-11-25
HUP0202314A2 (en) 2002-10-28
IT1306179B1 (it) 2001-05-30

Similar Documents

Publication Publication Date Title
AU6147401A (en) Compositions and methods for the treatment of cancer
HK1040944A1 (en) Methods and compositions for the prevention and treatment of anemia
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
IL127664A (en) Compositions for the treatment and prevention of cachexia
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
IL141426A0 (en) Compositions and methods for the treatment of tumor
GB9816234D0 (en) Compounds for use in the treatment of inflammation
IL143212A0 (en) Compositions and methods for the treatment of tumor
PL368035A1 (en) Compositions and methods for the treatment of cancer
IL147410A0 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
IL133760A0 (en) Composition for the treatment of dandruff
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
AU2566201A (en) Compounds and methods for the treatment of pain
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
GB9904252D0 (en) Composition for the treatment of pain
IL150202A0 (en) Method and composition for the treatment of pain